Search Results
May 26, 2026, 00:00 ET WuXi Vaccines' Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing
viral vectored, VLP, OMV, nucleic acid, conjugated vaccines). With its technical expertise, broad regulatory knowledge, premium quality system, advanced CMC development capabilities, multiple production platforms (cell culture, viral, microbial, polysaccharide and protein conjugation), and extensive GMP manufacturing
More news about: WuXi Vaccines
May 21, 2026, 17:34 ET Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
1:30 pm – 4:30 pm CTAbstract Number: 3086Poster Number: 223Presenter: Dr. Kuo-Ming Yu, Ph.D., Director, CMC and ProductionHighlightsSuperior Selectivity: Bispecific binding, enhancing internalization specifically
More news about: Formosa Pharmaceuticals Inc.,
May 21, 2026, 15:45 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
GTx-104 for the treatment of patients with aSAH." Per the press release, "the FDA referenced certain items in the Chemistry, Manufacturing, and Controls (CMC) and Non-Clinical sections of the application," which "are related to leachables data for product packaging, non-clinical product toxicology risk assessments,
More news about: Pomerantz LLP
May 20, 2026, 08:00 ET Outdoo AI Ranked #1 for Satisfaction in G2's AI Sales Roleplay Tools Category
and performance in high-stakes customer interactions.Trusted by Fortune 500 companies and global customer-facing teams including Globe Life, CMC, Sage, Wolters Kluwer, Keller Williams, Qure.ai, RAIN Group, Tensar, Providesure, and Sigvaris Group, Outdoo helps organizations strengthen how teams
More news about: Outdoo AI
May 19, 2026, 20:00 ET Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline
company. In this role, Dr. Hou will lead Antengene's efforts across Drug Discovery, Translational Medicine, and Chemistry, Manufacturing and Controls (CMC), with a focus on deepening the Company's research engine and building a pipeline of next-generation therapeutic candidates with transformational potential.Since
More news about: Antengene Corporation Limited
May 19, 2026, 08:30 ET Genedata Introduces AI-Native CMC Platform to Accelerate Drug Development and Manufacturing
Vico enables CMC data scientists to apply openly available, proprietary, or commercial AI models with full tracking, versioning, and lifecycle management.The solution enables teams across the full CMC organization to analyze, interrogate, and visualize data, with the support of CMC-domain-specific
More news about: Genedata
May 18, 2026, 21:35 ET Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC
bispecific antibody portfolios.We have established integrated capabilities across early discovery, translational medicine, clinical development, CMC and business development. The innovative nature and competitive strengths of our drug candidates, coupled with our global perspectives, proactive strategy,
More news about: Nanjing Leads Biolabs Co., Ltd.
May 18, 2026, 17:22 ET Joe Tunas Joins Partner Engineering and Science, Inc. as Technical Director, Environmental Health and Safety
disciplines, along with his network throughout the tristate area, will be invaluable to our clients who rely on us to solve evolving risks," said Brian Nemetz, CMC, National Technical Director of Industrial Hygiene and Health & Safety at Partner. "Beyond his impressive technical resume, Joe's passion for his
More news about: Partner Engineering and Science, Inc.
May 17, 2026, 21:13 ET El Día de la Innovación de ACROBiosystems llega a Zúrich
la aplicación clínica. Esto incluye el descubrimiento y la validación dirigidos, la selección y optimización de fármacos candidatos, el desarrollo de CMC y la producción piloto, la investigación preclínica, los ensayos clínicos, la producción comercial y la aplicación clínica de diagnósticos complementarios.Mediante
More news about: ACROBiosystems Group
May 17, 2026, 21:12 ET ACROBiosystems Innovation Day in Zürich bringt führende Köpfe zur Erkundung neuer Biotech-Grenzen zusammen
Produktion und klinischen Anwendung eingesetzt werden. Dazu gehören Target-Discovery und -Validierung, Screening/Optimierung von Wirkstoffkandidaten, CMC-Entwicklung und Pilotproduktion, präklinische Forschung, klinische Versuche, kommerzielle Produktion und klinische Anwendung von Begleitdiagnostika.Durch
More news about: ACROBiosystems Group
May 17, 2026, 21:10 ET Zurich accueille la journée de l'innovation d'ACROBiosystems : les plus grands esprits s'unissent pour explorer les frontières de la biotechnologie
l'application clinique. Cela comprend la découverte et la validation ciblées, le criblage et l'optimisation des médicaments candidats, le développement du CMC et la production pilote, la recherche préclinique, les essais cliniques, la production commerciale et l'application clinique des diagnostics compagnons.Grâce
More news about: ACROBiosystems Group
May 14, 2026, 23:01 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
GTx-104 for the treatment of patients with aSAH." Per the press release, "the FDA referenced certain items in the Chemistry, Manufacturing, and Controls (CMC) and Non-Clinical sections of the application," which "are related to leachables data for product packaging, non-clinical product toxicology risk assessments,
More news about: Pomerantz LLP
May 14, 2026, 14:02 ET Microcrystalline Cellulose (MCC) Market to Reach US$ 2.5 Billion Driven by Pharmaceutical Expansion and Functional Food Demand - Persistence Market Research
Cellulosic Thickeners Market by Product Type (Carboxymethyl Cellulose (CMC), Hydroxyethyl Cellulose (HEC), Others), Application (Food & Beverages, Pharmaceuticals, Others), Viscosity Grade (Low, Medium, High), and Regional
More news about: Persistence Market Research Pvt. Ltd.
May 14, 2026, 11:30 ET Zifo Minimizes Risk and Maximizes Compliance with AI-Powered Data Migration Solution
pipelines, and LLM-driven vector stores, Zifo ensures digital and data continuity is maintained from the earliest stages of Research & Discovery, through CMC, and into Clinical trials.Zifo's approach is more than just a technical exercise of moving data; it is a strategic enabler of digital transformation.
More news about: Zifo Technologies
May 13, 2026, 20:00 ET Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease
AriBio is a clinical-stage biopharmaceutical company headquartered in South Korea, with offices in the United States for global clinical development, CMC, and regulatory affairs. The company is focused on the development of novel therapies for neurodegenerative diseases, including Alzheimer's disease.
More news about: Fosun Pharma
May 12, 2026, 11:00 ET Porton Advanced and Dark Horse Consulting Group Announce Memorandum of Understanding Providing A Streamlined Path to Conducting IITs in China
accelerating the development and clinical translation of cell and gene therapies globally. This partnership unites DHCG's comprehensive regulatory, CMC, nonclinical, clinical, quality & compliance, supply chain, commercial launch, and business analytics consulting capabilities with Porton Advanced's
More news about: Porton Advanced
May 12, 2026, 09:00 ET Porton Advanced Stem Cell Exosomes Granted INCI Status, Advancing into Global Cosmetic Ingredient Market
Advanced has developed specialized CRO and CDMO platforms focusing on plasmids, viral vectors (lentiviral vector, adenoviral vector, AAV,etc), cell therapy CMC services including CAR-T, TCR-T, CAR-NK, HSC, exosome, etc) and nucleic acid therapies. Our state-of-the-art, GMP-compliant facilities span an impressive
More news about: Porton Advanced
May 12, 2026, 03:04 ET ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers
research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.Through
More news about: ACROBiosystems Group
May 11, 2026, 09:30 ET Zifo Now Partners with 7 of the Top 15 Global Biopharma Companies to Unblock the CMC Process Data Pipeline
transitioning those discoveries into clinical trials remains a severe bottleneck as the CMC process is currently very time-consuming and complex with estimates anywhere between 18-36 months.Every new therapy must undergo the CMC phase. To achieve this, companies must conduct extensive analytical testing and
More news about: Zifo Technologies
May 11, 2026, 07:00 ET Nanoscope Therapeutics to Present Advanced Clinical and Manufacturing Findings at ASGCT 2026 Annual Meeting
Poster #2207 (MCEC Hall B2-C Exhibit Level) – Dr. Amir Singh presentingChemistry, Manufacturing, and Controls (CMC) Challenges in Gene Therapy Regulatory Approvals: Insights from Approved Products and FDA Complete Response Letters, Wednesday, May 13, 05:00 PM - 06:30
More news about: Nanoscope Therapeutics
May 09, 2026, 13:30 ET ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.Through
More news about: ACROBiosystems Group
May 08, 2026, 11:00 ET Zifo Streamlines Regulatory Submissions with AI-Powered Document Authoring Solution
the manual and time-consuming process of creating complex regulatory submissions -- such as Clinical Study Reports (CSRs), Investigator Brochures, and CMC submissions -- streamlines first-draft timelines significantly. Leveraging Large Language Models (LLMs) and AI-assisted templating, this solution automates
More news about: Zifo Technologies
May 08, 2026, 08:45 ET Koppers Announces Conditional Plan to Discontinue Production Activities at Facility in Stickney, Illinois
justify the significant near‑term capital investment required at Stickney. While difficult, we feel this is a necessary step to strengthen our remaining CMC business and sharpen our focus on healthier, higher-growth markets that will drive more sustainable long-term profitability for our stakeholders."Mr.
More news about: KOPPERS HOLDINGS INC.
May 08, 2026, 08:45 ET KOPPERS REPORTS FIRST QUARTER 2026 RESULTS
Higher raw material costs were unfavorably impacted by scrap copper costs, net of the benefit realized from the company's copper-hedging program.CMC net sales decreased mainly due to lower phthalic anhydride volumes of $13.9 million as the company discontinued its production in the second quarter
More news about: KOPPERS HOLDINGS INC.
May 08, 2026, 04:17 ET Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to 'RZ-001' for Hepatocellular Carcinoma
development and partnership initiatives by initiating formal discussions with the FDA regarding clinical trial design, Chemistry, Manufacturing, and Controls (CMC), and commercialization strategies," said Sung-woo Hong, Vice President of Rznomics.Seong-Wook Lee, CEO of Rznomics, added, "Receiving RMAT designation
More news about: Rznomics